膿痂疹の世界市場レポート 2025年

膿痂疹市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.6％で、31億1,000万米ドルに成長します。予測期間の成長は、遠隔医療とe-pharmacyの拡大、政府と民間セクターの取り組み、皮膚感染症の有病率の上昇、小児人口の増加、皮膚科クリニックの需要増などに起因すると考えられます。この期間に予想される主な動向には、局所治療の進歩、新規抗菌剤の導入、戦略的提携やパートナーシップ、規制当局の承認、パイプラインの進歩などがあります。

皮膚感染症の有病率の増加が膿痂疹市場の拡大を牽引しています。皮膚感染症は、細菌、ウイルス、真菌、寄生虫などの有害な微生物が皮膚に侵入し、刺激、炎症、その他の症状を引き起こすことで発生します。皮膚感染症の増加には、抗生物質耐性、不衛生、気候変動、免疫力の低下、世界の旅行の増加など、いくつかの要因が関与しています。膿痂疹治療は、主にレンサ球菌やブドウ球菌などの細菌性病原体を標的とし、外用または経口の抗生物質を使用することで、感染症を管理する上で重要な役割を果たします。これにより、かゆみや不快感などの症状を緩和し、感染の拡大を防ぎ、治癒を早めることで、合併症や再発のリスクを軽減することができます。例えば2024年9月、英国の政府機関であるGOV.UKは、2022-2023会計年度の黄色ブドウ球菌菌血症の症例数を1万3,912件と報告し、前年度に比べて7.2％増加しました。その結果、皮膚感染症の有病率の増加が膿痂疹治療薬の需要を促進しています。

ヘルスケア施設の拡大も膿痂疹市場の主要促進要因のひとつです。病院、クリニック、診断センターなどのヘルスケア施設は、患者に必要不可欠な医療サービスを提供しています。投資の増加、患者中心のケアへの取り組み、人口増加、高齢化など、いくつかの要因がヘルスケアインフラの改善に寄与しています。ヘルスケア施設の充実は、専門的な皮膚科治療へのアクセス向上、効果的な治療選択肢の拡大、感染拡大防止のための衛生習慣の促進、早期診断とタイムリーな介入を可能にすることで、膿痂疹管理をサポートします。例えば、2023年5月、米国の非営利団体である米国医療協会によると、米国の病院数は6,129で、前年比0.59％増でした。ヘルスケア施設が改善されるにつれて、膿痂疹治療のアクセシビリティと有効性は高まり続けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界膿痂疹PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の膿痂疹市場：成長率分析
• 世界の膿痂疹市場の実績：規模と成長, 2019-2024
• 世界の膿痂疹市場の予測：規模と成長, 2024-2029, 2034F
• 世界膿痂疹総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の膿痂疹市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所抗生物質
• 経口抗生物質
• 消毒液の浸漬
• 世界の膿痂疹市場原因病原体別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 黄色ブドウ球菌
• 化膿レンサ球菌
• その他の細菌
• 世界の膿痂疹市場重症度別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 軽度
• 適度
• 厳しい
• 世界の膿痂疹市場患者の年齢別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 子供たち
• 大人
• お年寄り
• 世界の膿痂疹市場、局所抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ムピロシン
• レタパムリン
• フシジン酸
• 世界の膿痂疹市場経口抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• セファレキシン
• ジクロキサシリン
• クリンダマイシン
• 世界の膿痂疹市場消毒液の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クロルヘキシジン
• 過酸化水素
• 過マンガン酸カリウム

第7章 地域別・国別分析

• 世界の膿痂疹市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の膿痂疹市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 膿痂疹市場：競合情勢
• 膿痂疹市場：企業プロファイル
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sun Pharmaceutical Industries Ltd.
• Galderma SA
• Shionogi & Co. Ltd.
• Dr. Reddy's Laboratories Ltd.
• Leo Pharma A/S
• Torrent Pharmaceuticals Ltd.
• Almirall S.A
• Taro Pharmaceutical Industries Ltd.
• BioCryst Pharmaceuticals Inc.
• Melinta Therapeutics Inc.
• Cutanea Life Sciences Inc.
• InfectoPharm Arzneimittel und Consilium GmbH
• Medimetriks Pharmaceuticals Inc.
• NovaBay Pharmaceuticals Inc.
• Ferrer Internacional S.A

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 膿痂疹市場2029：新たな機会を提供する国
• 膿痂疹市場2029：新たな機会を提供するセグメント
• 膿痂疹市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Impetigo is a highly contagious bacterial skin infection primarily caused by *Streptococcus pyogenes*. It typically appears as red sores or blisters that break open, ooze, and develop a yellowish-brown crust. The infection spreads easily through direct skin-to-skin contact or by touching contaminated surfaces.

The primary treatment options for impetigo include topical antibiotics, oral antibiotics, and antiseptic soaks. Oral antibiotics, available in pill or liquid form, are typically prescribed for more severe or widespread infections. The infection can be caused by various pathogens, including Staphylococcus aureus, Streptococcus pyogenes, and other bacteria, with severity ranging from mild to moderate to severe. Impetigo affects different age groups, including children, adults, and the elderly.

The impetigo market research report is one of a series of new reports from The Business Research Company that provides impetigo market statistics, including impetigo industry global market size, regional shares, competitors with an impetigo market share, detailed impetigo market segments, market trends, and opportunities, and any further data you may need to thrive in the impetigo industry. This impetigo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The impetigo market size has grown strongly in recent years. It will grow from $2.25 billion in 2024 to $2.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the rising incidence of skin infections, improvements in healthcare infrastructure, increased access to telemedicine, greater public funding for infectious diseases, and the growing demand for topical treatments.

The impetigo market size is expected to see strong growth in the next few years. It will grow to $3.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the expansion of telemedicine and e-pharmacy, government and private sector initiatives, the rising prevalence of skin infections, pediatric population growth, and the increasing demand for dermatology clinics. Key trends expected during this period include advancements in topical treatments, the introduction of novel antimicrobial agents, strategic collaborations and partnerships, regulatory approvals, and pipeline advancements.

The increasing prevalence of skin infections is driving the expansion of the impetigo market. Skin infections occur when harmful microorganisms such as bacteria, viruses, fungi, or parasites invade the skin, leading to irritation, inflammation, or other symptoms. Several factors contribute to the rising occurrence of skin infections, including antibiotic resistance, poor hygiene, climate change, weakened immune systems, and increased global travel. Impetigo treatment plays a crucial role in managing the infection by targeting bacterial pathogens, primarily Streptococcus or Staphylococcus species, using topical or oral antibiotics. This helps alleviate symptoms such as itching and discomfort, prevents the infection from spreading, and accelerates healing, reducing the risk of complications and recurrence. For example, in September 2024, GOV.UK, a UK-based government agency, reported 13,912 cases of Staphylococcus aureus bacteremia during the 2022-2023 financial year, an increase of 7.2% compared to the previous year. As a result, the growing prevalence of skin infections is fueling the demand for impetigo treatments.

The expansion of healthcare facilities is another key driver of the impetigo market. Healthcare facilities, including hospitals, clinics, and diagnostic centers, provide essential medical services to patients. Several factors are contributing to the improvement of healthcare infrastructure, such as increased investments, patient-centered care initiatives, population growth, and aging demographics. Enhanced healthcare facilities support impetigo management by providing better access to specialized dermatological care, expanding the availability of effective treatment options, promoting hygiene practices to prevent infection spread, and enabling early diagnosis and timely intervention. For instance, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported that the United States had 6,129 hospitals, reflecting a 0.59% increase from the previous year. As healthcare facilities improve, the accessibility and effectiveness of impetigo treatment continue to grow.

The rise in healthcare spending is also a significant factor in the expansion of the impetigo market. Healthcare spending includes expenditures on medical care, hospital services, preventive care, medications, research, infrastructure, and administrative costs, all of which contribute to improving individual and public health. Increased healthcare spending is driven by an aging population, advancements in medical technology, a rising prevalence of chronic diseases, and growing demand for healthcare services. In the context of impetigo, higher healthcare expenditure supports the development of innovative treatments, improves access to critical care products, and enhances patient outcomes. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that UK healthcare spending grew by 5.6% between 2022 and 2023, compared to just 0.9% in 2022. The total healthcare expenditure in the UK reached approximately $317.63 billion (£292 billion) in 2023. Therefore, rising healthcare spending is further accelerating the growth of the impetigo market.

Major players in the impetigo market are Roche Holding AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Galderma SA, Shionogi & Co. Ltd., Dr. Reddy's Laboratories Ltd., Leo Pharma A/S, Torrent Pharmaceuticals Ltd., Almirall S.A, Taro Pharmaceutical Industries Ltd., BioCryst Pharmaceuticals Inc., Melinta Therapeutics Inc., Cutanea Life Sciences Inc., InfectoPharm Arzneimittel und Consilium GmbH, Medimetriks Pharmaceuticals Inc., NovaBay Pharmaceuticals Inc., Ferrer Internacional S.A.

North America was the largest region in the impetigo market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in impetigo report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the impetigo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The impetigo treatment market consists of sales of non-bullous impetigo, and bullous impetigo. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Impetigo Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on impetigo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for impetigo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The impetigo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Topical Antibiotics; Oral Antibiotics; Antiseptic Soaks
• 2) By Causative Pathogen: Staphylococcus aureus; Streptococcus pyogenes; Other Bacteria
• 3) By Severity: Mild; Moderate; Severe
• 4) By Patient Age: Children; Adults; Elderly
• Subsegments:
• 1) By Topical Antibiotics: Mupirocin; Retapamulin; Fusidic Acid
• 2) By Oral Antibiotics: Cephalexin; Dicloxacillin; Clindamycin
• 3) By Antiseptic Soaks: Chlorhexidine; Hydrogen Peroxide; Potassium Permanganate
• Companies Mentioned: Roche Holding AG; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Bausch Health Companies Inc.; Eisai Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Impetigo Market Characteristics

3. Impetigo Market Trends And Strategies

4. Impetigo Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Impetigo Growth Analysis And Strategic Analysis Framework

• 5.1. Global Impetigo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Impetigo Market Growth Rate Analysis
• 5.4. Global Impetigo Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Impetigo Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Impetigo Total Addressable Market (TAM)

6. Impetigo Market Segmentation

• 6.1. Global Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Antibiotics
• Oral Antibiotics
• Antiseptic Soaks
• 6.2. Global Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Staphylococcus aureus
• Streptococcus pyogenes
• Other Bacteria
• 6.3. Global Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild
• Moderate
• Severe
• 6.4. Global Impetigo Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• Elderly
• 6.5. Global Impetigo Market, Sub-Segmentation Of Topical Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mupirocin
• Retapamulin
• Fusidic Acid
• 6.6. Global Impetigo Market, Sub-Segmentation Of Oral Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cephalexin
• Dicloxacillin
• Clindamycin
• 6.7. Global Impetigo Market, Sub-Segmentation Of Antiseptic Soaks, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chlorhexidine
• Hydrogen Peroxide
• Potassium Permanganate

7. Impetigo Market Regional And Country Analysis

• 7.1. Global Impetigo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Impetigo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Impetigo Market

• 8.1. Asia-Pacific Impetigo Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Impetigo Market

• 9.1. China Impetigo Market Overview
• 9.2. China Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Impetigo Market

• 10.1. India Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Impetigo Market

• 11.1. Japan Impetigo Market Overview
• 11.2. Japan Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Impetigo Market

• 12.1. Australia Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Impetigo Market

• 13.1. Indonesia Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Impetigo Market

• 14.1. South Korea Impetigo Market Overview
• 14.2. South Korea Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Impetigo Market

• 15.1. Western Europe Impetigo Market Overview
• 15.2. Western Europe Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Impetigo Market

• 16.1. UK Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Impetigo Market

• 17.1. Germany Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Impetigo Market

• 18.1. France Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Impetigo Market

• 19.1. Italy Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Impetigo Market

• 20.1. Spain Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Impetigo Market

• 21.1. Eastern Europe Impetigo Market Overview
• 21.2. Eastern Europe Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Impetigo Market

• 22.1. Russia Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Impetigo Market

• 23.1. North America Impetigo Market Overview
• 23.2. North America Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Impetigo Market

• 24.1. USA Impetigo Market Overview
• 24.2. USA Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Impetigo Market

• 25.1. Canada Impetigo Market Overview
• 25.2. Canada Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Impetigo Market

• 26.1. South America Impetigo Market Overview
• 26.2. South America Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Impetigo Market

• 27.1. Brazil Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Impetigo Market

• 28.1. Middle East Impetigo Market Overview
• 28.2. Middle East Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Impetigo Market

• 29.1. Africa Impetigo Market Overview
• 29.2. Africa Impetigo Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Impetigo Market, Segmentation By Causative Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Impetigo Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Impetigo Market Competitive Landscape And Company Profiles

• 30.1. Impetigo Market Competitive Landscape
• 30.2. Impetigo Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Impetigo Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Ltd.
• 31.2. Galderma SA
• 31.3. Shionogi & Co. Ltd.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Leo Pharma A/S
• 31.6. Torrent Pharmaceuticals Ltd.
• 31.7. Almirall S.A
• 31.8. Taro Pharmaceutical Industries Ltd.
• 31.9. BioCryst Pharmaceuticals Inc.
• 31.10. Melinta Therapeutics Inc.
• 31.11. Cutanea Life Sciences Inc.
• 31.12. InfectoPharm Arzneimittel und Consilium GmbH
• 31.13. Medimetriks Pharmaceuticals Inc.
• 31.14. NovaBay Pharmaceuticals Inc.
• 31.15. Ferrer Internacional S.A

32. Global Impetigo Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Impetigo Market

34. Recent Developments In The Impetigo Market

35. Impetigo Market High Potential Countries, Segments and Strategies

• 35.1 Impetigo Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Impetigo Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Impetigo Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer